These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30246346)

  • 1. Chronic hand eczema in Germany: 5-year follow-up data from the CARPE registry.
    Apfelbacher CJ; Ofenloch RF; Weisshaar E; Molin S; Bauer A; Mahler V; Heinrich A; von Kiedrowski R; Schmitt J; Elsner P; Diepgen TL
    Contact Dermatitis; 2019 Jan; 80(1):45-53. PubMed ID: 30246346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CARPE: a registry project of the German Dermatological Society (DDG) for the characterization and care of chronic hand eczema.
    Apfelbacher CJ; Akst W; Molin S; Schmitt J; Bauer A; Weisshaar E; Mahler V; Treichel S; Ruzicka T; Luger T; Elsner P; Diepgen TL
    J Dtsch Dermatol Ges; 2011 Sep; 9(9):682-8. PubMed ID: 21564539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and provision of care in patients with chronic hand eczema: updated data from the CARPE registry.
    Apfelbacher C; Molin S; Weisshaar E; Bauer A; Elsner P; Mahler V; Weiss M; Ruzicka T; Diepgen TL
    Acta Derm Venereol; 2014 Mar; 94(2):163-7. PubMed ID: 23995048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hand eczema and steroid-refractory chronic hand eczema in general practice: prevalence and initial treatment.
    Crane MM; Webb DJ; Watson E; Cunliffe T; English J
    Br J Dermatol; 2017 Apr; 176(4):955-964. PubMed ID: 27534443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hand eczema: A prospective analysis of the Swiss CARPE registry focusing on factors associated with clinical and quality of life improvement.
    Cazzaniga S; Ballmer-Weber BK; Gräni N; Spring P; Bircher A; Anliker M; Sonntag AK; Piletta P; Huber C; Diepgen TL; Apfelbacher C; Naldi L; Borradori L; Simon D
    Contact Dermatitis; 2018 Sep; 79(3):136-148. PubMed ID: 29943397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alitretinoin for the treatment of severe chronic hand eczema.
    Paulden M; Rodgers M; Griffin S; Slack R; Duffy S; Ingram JR; Woolacott N; Sculpher M
    Health Technol Assess; 2010 May; 14 Suppl 1():39-46. PubMed ID: 20507802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol: efficacy of oral alitretinoin versus oral cyclosporine A in patients with severe recurrent vesicular hand eczema (ALICsA): a randomised prospective open-label trial with blinded outcome assessment.
    Oosterhaven JAF; Schuttelaar MLA
    BMJ Open; 2018 Jul; 8(7):e020192. PubMed ID: 29997136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hand eczema registries: Background, value and future prospects : Registry data in hand eczema research].
    Ofenloch R; Apfelbacher C; Weisshaar E
    Hautarzt; 2018 Oct; 69(10):809-814. PubMed ID: 30135968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which factors are associated with the use of systemic antihistamines in patients with chronic hand eczema? Results from the CARPE registry.
    Apfelbacher C; Weiß M; Molin S; Bauer A; Mahler V; Schmitt J; Elsner P; Diepgen TL; Weisshaar E
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):50-6. PubMed ID: 26466833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Itching in patients with chronic hand eczema: data from the CARPE registry.
    Ruppert L; Apfelbacher C; Molin S; Bauer A; Mahler V; Schmitt J; Elsner P; Diepgen TL; Weisshaar E
    Dermatology; 2014; 229(2):146-53. PubMed ID: 25138355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact on quality of life of alitretinoin in severe chronic hand eczema: FUGETTA real-world study.
    Augustin M; Thaçi D; Kamps A
    J Dtsch Dermatol Ges; 2016 Dec; 14(12):1261-1270. PubMed ID: 27992140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Study of Efficacy Between Cyclosporine and Alitretinoin in Patients With Chronic Hand Eczema.
    Jang JH; Joh HC; Song CH; Kim KY; Jue MS; Ro YS; Ko JY
    Dermatitis; 2024; 35(3):258-265. PubMed ID: 37870578
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
    Ruzicka T; Lynde CW; Jemec GB; Diepgen T; Berth-Jones J; Coenraads PJ; Kaszuba A; Bissonnette R; Varjonen E; Holló P; Cambazard F; Lahfa M; Elsner P; Nyberg F; Svensson A; Brown TC; Harsch M; Maares J
    Br J Dermatol; 2008 Apr; 158(4):808-17. PubMed ID: 18294310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
    Schmitt J; Abraham S; Trautmann F; Stephan V; Fölster-Holst R; Homey B; Bieber T; Novak N; Sticherling M; Augustin M; Kleinheinz A; Elsner P; Weidinger S; Werfel T
    J Dtsch Dermatol Ges; 2017 Jan; 15(1):49-59. PubMed ID: 27862987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-of-illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany.
    Augustin M; Kuessner D; Purwins S; Hieke K; Posthumus J; Diepgen TL
    Br J Dermatol; 2011 Oct; 165(4):845-51. PubMed ID: 21623744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
    Fowler JF; Graff O; Hamedani AG
    J Drugs Dermatol; 2014 Oct; 13(10):1198-204. PubMed ID: 25607554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DECISA Project (DErmatology Clinics in Italy: Survey on Alitretinoin): A real-life retrospective cohort multicenter study on 438 subjects with chronic hand eczema.
    Ferrucci S; Persichini P; Gola M; Scandagli I; Pigatto P; Legori A; Musumeci ML; Micali G; D'Agata E; Schena D; Azzolini A; Gallo R; Trave I; Cristaudo A; Patruno C; Napolitano M; Zucca M; Piras V; Stingeni L; Bianchi L; Corazza M; Zedde P; Foti C; Romita P; Cannavò SP; Guarneri F
    Dermatol Ther; 2021 May; 34(3):e14911. PubMed ID: 33619833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alitretinoin and acitretin in severe chronic hand eczema; results from a retrospective daily practice study.
    Politiek K; Christoffers WA; Coenraads PJ; Schuttelaar MA
    Dermatol Ther; 2016 Sep; 29(5):364-371. PubMed ID: 27146260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of chronic hand eczema: a semantic map analysis of the CARPE registry data.
    Cazzaniga S; Apfelbacher C; Diepgen T; Ofenloch RF; Weisshaar E; Molin S; Bauer A; Mahler V; Elsner P; Schmitt J; Ballmer-Weber BK; Spring P; Naldi L; Borradori L; Simon D;
    Br J Dermatol; 2018 Jan; 178(1):229-237. PubMed ID: 28498524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of alitretinoin in severe chronic hand eczema: PASSION, a real-world observational study.
    Thaçi D; Augustin M; Westermayer B; Kamps A; Hennig M
    J Dermatolog Treat; 2016 Nov; 27(6):577-583. PubMed ID: 27618281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.